co.don AG Logo

co.don AG

Develops autologous cell therapies for regenerative treatment of cartilage defects.

CNW | F

Overview

Corporate Details

ISIN(s):
DE000A3E5C08 (+1 more)
LEI:
3912006R73YW0SX1KG21
Country:
Germany
Address:
Warthestr. 21, 14513 Teltow

Description

co.don AG is a biopharmaceutical company specializing in tissue engineering and regenerative medicine. The company develops, manufactures, and markets autologous cell therapies for the minimally invasive, regenerative treatment of articular cartilage defects. Its core technology involves cultivating a patient's own cartilage cells (chondrocytes) and forming them into three-dimensional spheroids. This product, known as Spherox, is then implanted into the damaged knee cartilage to promote natural tissue regeneration. This personalized therapeutic approach aims to restore joint function and provide a durable, biological solution for cartilage repair.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-30 00:00
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
German 142.4 KB
2022-09-29 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
German 6.4 KB
2022-07-11 00:00
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
German 1.3 MB
2022-07-06 00:00
Berichtigung der Veröffentlichung vom 14.06.2022
German 6.4 KB
2022-06-14 00:00
Berichtigt am 06.07.2022
German 6.4 KB
2022-04-29 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
German 6.4 KB
2021-09-11 00:00
CO.DON AG: Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
German 13.9 KB
2021-08-30 00:00
Halbjahresfinanzbericht
German 148.6 KB
2021-05-27 00:00
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
German 4.2 KB
2021-05-25 00:00
Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
German 4.2 KB
2021-05-22 00:00
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
English 11.8 KB
2020-08-28 00:00
Datum:28.08.2020
German 381.2 KB
2020-08-24 00:00
Datum:24.08.2020
German 12.2 KB
2020-07-28 00:00
Datum:28.07.2020
German 998.8 KB
2020-07-07 00:00
Datum:07.07.2020
German 41.3 KB

Automate Your Workflow. Get a real-time feed of all co.don AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for co.don AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for co.don AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-10-20 Laik, Jonathan Close relation Other None 25,994.00 EUR
2021-10-20 Friedrich, Julia Close relation Other None 19,500.00 EUR
2021-10-20 MMI Leisure & Capital Management GmbH Close relation Buy None 4,500.00 EUR
2021-10-19 Seidel, Marcus Supervisory board Buy None 33,105.80 EUR
2021-10-18 Bauerfeind Beteiligungsgesellschaft mbH Close relation Other None 3,882,975.20 EUR
2021-10-18 Bauerfeind Beteiligungsgesellschaft mbH Close relation Other None 1,439,447.10 EUR
2021-10-18 Ceccaldi, Julie Close relation Sell None 23,377.60 EUR
2021-10-18 Pierer Industrie AG Close relation Other None 18,430.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.